1. Translesion DNA Synthesis and Reinitiation of DNA Synthesis in Chemotherapy Resistance
   E. S. Shilkin et al, 2020, Biochemistry (Moscow) CrossRef
2. Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
   Michael F. Sharpnack et al, 2020, Lung Cancer CrossRef
3. DNA Repair and Therapeutic Strategies in Cancer Stem Cells
   Matthew S. Gillespie et al, 2023, Cancers CrossRef
4. MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L
   Roshini Arivazhagan et al, 2018, Oncotarget CrossRef
5. Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain
   Fangjin Huang et al, 2020, BMC Medical Genetics CrossRef
6. Post-replication repair: Rad5/HLTF regulation, activity on undamaged templates, and relationship to cancer
   David Gallo et al, 2019, Critical Reviews in Biochemistry and Molecular Biology CrossRef
7. Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
   M. Teresa Agulló-Ortuño et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
8. Circular RNA PRMT5 confers cisplatin‐resistance via miR‐4458/REV3L axis in non‐small‐cell lung cancer
   Jun Pang et al, 2020, Cell Biology International CrossRef
9. Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
   Shaloam Dasari et al, 2022, International Journal of Molecular Sciences CrossRef
10. Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
    Marianna Macerelli et al, 2016, Cancer Treatment Reviews CrossRef
11. A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas
    Djihad Hadjadj et al, 2017, Aging CrossRef
12. DNA polymerase ζ suppresses the radiosensitivity of glioma cells by regulating the PI3K/AKT/mTOR pathway
    Jiqiang Ding et al, 2023, Autoimmunity CrossRef
13. Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells
    Linghao Kong et al, 2018, Biochemical and Biophysical Research Communications CrossRef
14. New Approaches for Quantitative Reconstruction of Radiation Dose in Human Blood Cells
    Shanaz A. Ghandhi et al, 2019, Scientific Reports CrossRef
15. Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma
    Dan Wang et al, 2020, Open Life Sciences CrossRef
16. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
    Luciana Rodrigues Gomes et al, 2019, Cell Death & Disease CrossRef
17. DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
    Yang Zhao et al, 2022, Frontiers in Molecular Biosciences CrossRef
18. Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
    Kinrin Yamanaka et al, 2017, PLOS Genetics CrossRef
19. MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L
    Xialin Chen et al, 2018, Molecular Medicine Reports CrossRef
20. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway
    Gang Huang et al, 2019, Aging CrossRef
21. miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
    Priya Samuel et al, 2016, Expert Review of Anticancer Therapy CrossRef
22. DNA polymerases in the risk and prognosis of colorectal and pancreatic cancers
    Roberto Silvestri et al, 2019, Mutagenesis CrossRef
23. Underappreciated Roles of DNA Polymerase δ in Replication Stress Survival
    Jeannette Fuchs et al, 2021, Trends in Genetics CrossRef
24. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
    Paul B Tchounwou et al, 2021, Journal of Experimental Pharmacology CrossRef